Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

Condition:   Soft Tissue Sarcoma Interventions:   Drug: ADI PEG20;   Other: Placebo Sponsor:   Polaris Group Not yet recruiting

Source: ClinicalTrials.gov - February 3, 2023 Category: Research Source Type: clinical trials